GSP Crop Science IPO
Open Date
16 Mar 2026
Close Date
18 Mar 2026
Open Date
16 Mar 2026
Close Date
18 Mar 2026
Min Investment
Lot Size
Issue Size
Price Range
Subscribed

Founded In
1985
Director
Apurva Soham Mashruwala
Financials of Gsp Crop Science IPO
| Key Performance Indicators | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating Revenue | 1,203.31 | 1,152.16 | 1,287.39 |
| Other Income | 2.74 | 6.07 | 13.67 |
Total Income | 1,206.05 | 1,158.23 | 1,301.06 |
Total Expenses | 1,182.72 | 1,081.67 | 1,191.38 |
| Profit Before Tax | 23.32 | 76.56 | 109.68 |
Total Profit | 21.55 | 61.29 | 82.14 |
All figures are in crores (₹)

Utilisation of Proceeds
All figures are in crores (₹)
| Purpose | Amount |
|---|---|
| The company proposes to utilize the net proceeds towards repayment/prepayment of borrowings to reduce outstanding indebtedness, maintain favorable debt-equity ratio, reduce interest outflow and enable utilization of internal accruals for business growth and expansion. | 170 |
| The company proposes to deploy the balance net proceeds towards general corporate purposes including strategic initiatives, funding growth opportunities, expansion initiatives, brand building and meeting expenses incurred in ordinary course of business. | - |

- Well-diversified product portfolio including a wide range of insecticides, herbicides, fungicides, and plant growth regulators: The company has 524 registrations across Formulations and Technicals as of September 30, 2025, with revenue from Formulations at 71.81% and Technicals at 28.19% for the six months ended September 30, 2025.
- Catering to a large and diverse clientele both domestically as well as internationally: The company serves customers in 37 countries with long-standing relationships over 10 years, including agrochemical companies like Bharat Rasayan Limited and Dharmaj Crop Guard Limited, ensuring minimal reliance on any single client.
- Strong in-house R&D capabilities with focus on innovation and product development: The company has been granted 102 patents as of the date of the Red Herring Prospectus with 108 patent applications under process, and revenue from patented products was ₹1,436.75 million (17.10% of sales) for six months ended September 30, 2025.
- Robust manufacturing facilities with ability to manufacture a wide range of products with a focus on sustainability: The company operates five manufacturing facilities with annual aggregated installed capacity of 15,120 MTPA for Technicals, 43,672 MTPA for Formulations and 5,400 MTPA for Intermediates as of September 30, 2025.
- Led by qualified and experienced Promoters and supported by a professional management team: The company has an employee base of 1,221 permanent employees as of September 30, 2025, with a dedicated R&D staff of 35 employees, 5 of whom hold PhDs, providing competitive advantage for business expansion.

